Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $36000.0.

  • Atara Biotherapeutics' Depreciation & Amortization (CF) fell 9707.32% to $36000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 3857.64%. This contributed to the annual value of $5.1 million for FY2024, which is 459.72% up from last year.
  • Latest data reveals that Atara Biotherapeutics reported Depreciation & Amortization (CF) of $36000.0 as of Q3 2025, which was down 9707.32% from $236000.0 recorded in Q2 2025.
  • Atara Biotherapeutics' 5-year Depreciation & Amortization (CF) high stood at $1.8 million for Q1 2025, and its period low was $36000.0 during Q3 2025.
  • In the last 4 years, Atara Biotherapeutics' Depreciation & Amortization (CF) had a median value of $1.2 million in 2024 and averaged $1.2 million.
  • Over the last 5 years, Atara Biotherapeutics' Depreciation & Amortization (CF) had its largest YoY gain of 2904.39% in 2025, and its largest YoY loss of 9707.32% in 2025.
  • Over the past 4 years, Atara Biotherapeutics' Depreciation & Amortization (CF) (Quarter) stood at $1.3 million in 2022, then decreased by 3.98% to $1.2 million in 2023, then fell by 8.71% to $1.1 million in 2024, then tumbled by 96.73% to $36000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $36000.0 for Q3 2025, versus $236000.0 for Q2 2025 and $1.8 million for Q1 2025.